Elevated Pretreatment Serum Levels of Interferon-inducible Protein-10 (CXCL10) Predict Disease Relapse and Prognosis in Diffuse Large B-Cell Lymphoma Patients

While standard clinical prognostic factors predict outcome in diffuse large B-cell lymphoma (DLBCL), predicting the outcome of patients might be further refined using biological factors. We tested whether serum cytokines could provide prognostic information in DLBCL patients. Thirty cytokines were m...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ansell, Stephen M., Maurer, Matthew J., Ziesmer, Steven C., Slager, Susan L., Habermann, Thomas M., Link, Brian K., Witzig, Thomas E., Macon, William R., Dogan, Ahmet, Cerhan, James R., Novak, Anne J.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3429646/
https://ncbi.nlm.nih.gov/pubmed/22674570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23259
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires